Want to see TSE:MDNA full AI Analyst Report?
Medicenna Therapeutics Corp (MDNA) Financial Statements
Medicenna Therapeutics Corp Financial Overview
Medicenna Therapeutics Corp's market cap is currently $35.32M. The company's EPS TTM is $-0.22; its P/E ratio is -2.06; Medicenna Therapeutics Corp is estimated to report earnings on November 12, 2026, and the estimated EPS forecast is $-0.04. See an overview of income statement, balance sheet, and cash flow financials.
| Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ -77.00K | $ -55.00K | $ -5.00K | $ -5.00K | $ -38.00K |
| Operating Income | $ -23.71M | $ -21.63M | $ -19.66M | $ -21.64M | $ -22.30M |
| EBITDA | $ -23.64M | $ -12.98M | $ -18.67M | $ -16.30M | $ -22.54M |
| Net Income | $ -18.41M | $ -11.80M | $ -25.47M | $ 1.55M | $ -22.65M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 6.25M | $ 24.84M | $ 16.98M | $ 33.60M | $ 20.54M |
| Total Assets | $ 8.45M | $ 28.38M | $ 19.13M | $ 36.45M | $ 23.46M |
| Total Debt | $ 119.00K | $ 168.00K | $ 0.00 | $ 0.00 | $ 0.00 |
| Net Debt | $ -6.13M | $ -24.67M | $ -16.98M | $ -33.60M | $ -20.54M |
| Total Liabilities | $ 5.97M | $ 9.29M | $ 13.94M | $ 6.96M | $ 2.62M |
| Stockholders' Equity | $ 2.48M | $ 19.09M | $ 5.19M | $ 29.49M | $ 20.84M |
| Cash Flow | |||||
| Free Cash Flow | $ 0.00 | $ -16.52M | $ -16.26M | $ -12.66M | $ -23.58M |
| Operating Cash Flow | $ -17.92M | $ -16.49M | $ -16.26M | $ -12.66M | $ -23.58M |
| Investing Cash Flow | $ 2.00K | $ -33.00K | $ 0.00 | $ -13.05M | $ 10.05M |
| Financing Cash Flow | $ -19.00K | $ 23.49M | $ 0.00 | $ 24.76M | $ 3.88M |
Currency in CAD